Commerzbank Aktiengesellschaft Abiomed Inc Transaction History

Commerzbank Aktiengesellschaft

$3.75 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 21, 2020	SELL	$141.4 - $257.09 $606,040 - $1.1 Million	-4,286 Closed	0 $0
Q1 2020 Oct 03, 2024	BUY	$130.51 - $196.01 $559,365 - $840,098	4,286 New	4,286 $622,000
Q1 2020 Apr 29, 2020	SELL	$130.51 - $196.01 $1.43 Million - $2.15 Million	-10,984 Reduced 71.93%	4,286 $622,000
Q4 2019 Oct 03, 2024	BUY	$159.31 - $223.54 $2.43 Million - $3.41 Million	15,270 New	15,270 $2.61 Million
Q4 2019 Jan 17, 2020	BUY	$159.31 - $223.54 $582,118 - $816,815	3,654 Added 31.46%	15,270 $2.61 Million
Q3 2019 Oct 03, 2024	BUY	$175.89 - $279.23 $2.04 Million - $3.24 Million	11,616 New	11,616 $2.07 Million
Q3 2019 Oct 17, 2019	BUY	$175.89 - $279.23 $1.3 Million - $2.06 Million	7,384 Added 174.48%	11,616 $2.07 Million
Q2 2019 Oct 03, 2024	BUY	$250.96 - $284.94 $1.06 Million - $1.21 Million	4,232 New	4,232 $1.1 Million
Q2 2019 Jul 23, 2019	BUY	$250.96 - $284.94 $690,140 - $783,585	2,750 Added 185.56%	4,232 $1.1 Million
Q1 2019 Oct 03, 2024	BUY	$276.39 - $362.25 $409,609 - $536,854	1,482 New	1,482 $423,000
Q1 2019 May 13, 2019	SELL	$276.39 - $362.25 $790,199 - $1.04 Million	-2,859 Reduced 65.86%	1,482 $423,000
Q4 2018 Oct 03, 2024	BUY	$281.08 - $444.25 $1.22 Million - $1.93 Million	4,341 New	4,341 $1.41 Million
Q4 2018 Feb 06, 2019	BUY	$281.08 - $444.25 $727,716 - $1.15 Million	2,589 Added 147.77%	4,341 $1.41 Million
Q3 2018 Oct 04, 2024	BUY	$354.53 - $449.75 $621,136 - $787,962	1,752 New	1,752 $788,000
Q3 2018 Nov 13, 2018	SELL	$354.53 - $449.75 $20,208 - $25,635	-57 Reduced 3.15%	1,752 $788,000
Q2 2018 Oct 04, 2024	BUY	$278.07 - $446.21 $503,028 - $807,193	1,809 New	1,809 $740,000
Q2 2018 Aug 10, 2018	BUY	$278.07 - $446.21 $503,028 - $807,193	1,809 New	1,809 $740,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.

Account